herceptin
News/ News/ Sales and Marketing/ Top stories
Amgen’s cancer biosimilars stay on US market as court battle with Roche ends
Richard Staines
Amgen, Avastin, biosimilars, cancer, Genentech, herceptin, litigation, patent, Roche
0 Comment
News/ News/ Sales and Marketing
Roche raises 2019 outlook, shrugging off biosimilar threat
Phil Taylor
Avastin, biosimilar, Hemlibra, herceptin, Ocrevus, Rituxan, Roche, Tecentriq
0 Comment
New deals extend Mundipharma biosimilar reach
Phil Taylor
biosimilar, herceptin, Mundipharma, Roche
0 Comment
Market Access/ News/ News/ News/ Oncology
Roche seeks Kadcyla boost to fend off Herceptin biosimilars
George Underwood
breast cancer, herceptin, Kadclya, Roche
0 Comment
Market Access/ News/ News/ News/ Oncology
Pfizer wins Herceptin biosimilar approval in Europe
Piotr Wnuk
biosimilar, breast cancer, European Commission, HER2-positive breast cancer, herceptin, Oncology, Pfizer, Trazimera
0 Comment
Cancer/ Healthcare/ News/ UK & Europe
MSD launches first Herceptin biosimilar in UK
Andrew McConaghie
biosimilars, herceptin
0 Comment
Ontruzant, the first biosimilar version of Roche’s Herceptin (trastuzumab) in Europe has been launched in the UK by MSD.
Healthcare/ News/ News/ Oncology/ Pharma Market Access/ UK & Europe
Its Herceptin biosimilar nearing launch, Celltrion begins work on Keytruda copy
Andrew McConaghie
biosimilars, Celltrion, herceptin, Keytruda, Roche
0 Comment
Samsung Bioepis files Herceptin biosimilar in EU
Richard Staines
biosimilars, ema, herceptin, Roche, Samsung Bioepis
0 Comment
South Korean firm trying to copy breast cancer blockbuster.